DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. Our mission is to improve the lives of those debilitated by degenerative diseases of the spine through innovative regenerative therapies.